These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 683623)

  • 21. [Detection of fetal growth retardation by instrumental and biochemical monitoring methods].
    Pfeiffer KH
    Z Geburtshilfe Perinatol; 1990; 194(3):99-103. PubMed ID: 2198727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prenatal diagnosis and treatments of intrauterine growth retardation (author's transl)].
    Kaneoka T; Shimizu H; Matsuoka I; Taguchi S; Shirakawa K
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Feb; 34(2):233-42. PubMed ID: 7061905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Echographic and hormonal parameters in fetal growth retardation].
    Ruseva R
    Akush Ginekol (Sofiia); 1988; 27(5):15-8. PubMed ID: 3066230
    [No Abstract]   [Full Text] [Related]  

  • 24. Which is the best placental function test? A comparison of placental lactogen and unconjugated oestriol in the prediction of intrauterine growth retardation.
    Chard T; Sturdee J; Cockrill B; Obiekwe BC
    Eur J Obstet Gynecol Reprod Biol; 1985 Jan; 19(1):13-7. PubMed ID: 3979650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Value of total serum oestriol and human placental lactogen in the assessment of fetal-placental function.
    Isouard G
    Aust N Z J Obstet Gynaecol; 1979 May; 19(2):69-76. PubMed ID: 292431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of human placental lactogen, oxytocinase and estriol in twin pregnancies with intrauterine growth retardation.
    Briët JW; Hoorn RK
    Eur J Obstet Gynecol Reprod Biol; 1982 Feb; 13(1):7-14. PubMed ID: 7060818
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measurement of placental protein 5, placental lactogen and pregnancy-specific beta 1 glycoprotein in mid-trimester as a predictor of outcome of pregnancy.
    Salem HT; Lee JN; Seppälä M; Vaara L; Aula P; Al-Ani AT; Chard T
    Br J Obstet Gynaecol; 1981 Apr; 88(4):371-4. PubMed ID: 6971651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The diagnosis and management of intra-uterine growth retardation.
    Leader LR; Woods DL
    S Afr Med J; 1980 Oct; 58(15):605-8. PubMed ID: 6999639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation between human placental lactogen levels and glucose metabolism in pregnant women with intrauterine growth retardation.
    Bagga R; Vasishta K; Majumdar S; Garg SK
    Aust N Z J Obstet Gynaecol; 1990 Nov; 30(4):310-3. PubMed ID: 2082885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Relation of placental prolactogen and E3 in the blood of pregnant women to placental grading by ultrasonography and its clinical significance].
    Wang SQ
    Zhonghua Fu Chan Ke Za Zhi; 1989 Jul; 24(4):220-3, 252-3. PubMed ID: 2695301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Single radial immunodiffusion of human placental lactogen and its clinical uses].
    Zhang WY
    Zhonghua Fu Chan Ke Za Zhi; 1990 Sep; 25(5):278-81, 316. PubMed ID: 2126505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Criteria for the diagnosis, management and treatment of intrauterine growth retardation].
    Pommier M
    Ginecol Obstet Mex; 1978 Oct; 44(264):335-45. PubMed ID: 720873
    [No Abstract]   [Full Text] [Related]  

  • 33. [Human placental lactogen in fetal hypotrophy].
    Ruseva R; Marinov B; Vlasova D
    Akush Ginekol (Sofiia); 1988; 27(2):18-21. PubMed ID: 3414896
    [No Abstract]   [Full Text] [Related]  

  • 34. [The determination of human placental lactogen (HPL) for hormonal supervision in late pregnancy].
    Nieder J; Kapitza W
    Zentralbl Gynakol; 1976; 98(18):1129-36. PubMed ID: 983489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HPL as indicator of intrauterine malnutrition.
    Kyank HR
    J Perinat Med; 1985; 13(2):100-1. PubMed ID: 4009384
    [No Abstract]   [Full Text] [Related]  

  • 36. The effectiveness of human placental lactogen measurements as an adjunct in decreasing perinatal deaths. Results of a retrospective and a randomized controlled prospective study.
    Spellacy WN; Buhi WC; Birk SA
    Am J Obstet Gynecol; 1975 Mar; 121(6):835-44. PubMed ID: 1091148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro differentiation of villous trophoblasts from pregnancies complicated by intrauterine growth restriction with and without pre-eclampsia.
    Newhouse SM; Davidge ST; Winkler-Lowen B; Demianczuk N; Guilbert LJ
    Placenta; 2007 Oct; 28(10):999-1003. PubMed ID: 17559930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human placental lactogen serum levels in venous and capillary blood from women in late pregnancy.
    Axelsson O; Malmström H
    Gynecol Obstet Invest; 1983; 15(1):19-25. PubMed ID: 6822371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serial measurements of serum human placental lactogen (hPL) and serial ultrasound examinations in the evaluation of fetal growth.
    Sørensen S; von Tabouillot D; Schioler V; Greisen G; Petersen S; Larsen T
    Early Hum Dev; 2000 Nov; 60(1):25-34. PubMed ID: 11054581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measurement of plasma placental proteins and estriol in the detection of intrauterine growth retardation.
    Nisbet AD; Horne CH; Jandial V; Bremner RD; Cruickshank N; Sutcliffe RG
    Eur J Obstet Gynecol Reprod Biol; 1982 Sep; 13(6):333-42. PubMed ID: 6182039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.